Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders.
The company has developed a proprietary device called SonoCloud®, which emits ultrasound to temporarily increase the permeability of the blood vessels in the brain. The device increases the therapeutic efficacy of new and existing therapies to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimer’s Disease, ALS).
- Invested amount
EUR 10 599 936